Perrigo Company plc Operating Cash Flow
Perrigo Company plc (PRGO) reported Operating Cash Flow of -$31.00 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- Perrigo Company plc net cash provided by (used in) operating activities for the quarter ending 2026-06-27 was $82.60M, a 8.83% increase year-over-year.
- Perrigo Company plc net cash provided by (used in) operating activities for the quarter ending 2026-03-28 was -$113.60M.
- Perrigo Company plc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $175.40M, a 43.89% decline year-over-year.
- Perrigo Company plc net cash provided by (used in) operating activities for the quarter ending 2025-09-27 was $51.70M, a 22.51% increase year-over-year.
- Perrigo Company plc net cash provided by (used in) operating activities for fiscal 2025 was $238.50M, a 34.28% decline from fiscal 2024.
- Perrigo Company plc net cash provided by (used in) operating activities for fiscal 2024 was $362.90M, a 10.51% decline from fiscal 2023.
- Perrigo Company plc net cash provided by (used in) operating activities for fiscal 2023 was $405.50M, a 31.96% increase from fiscal 2022.
- Perrigo Company plc net cash provided by (used in) operating activities for fiscal 2022 was $307.30M, a 96.61% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $82.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$31.00M 10-Q · filed 2026-08-05 | $144.40M derived: sum of 3 quarters · filed 2026-08-05 | $196.10M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | -$113.60M 10-Q · filed 2026-05-06 | $61.80M derived: sum of 2 quarters · filed 2026-05-06 | $113.50M derived: sum of 3 quarters · filed 2026-05-06 | $189.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $175.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $227.10M derived: sum of 2 quarters · filed 2026-02-26 | $303.00M derived: sum of 3 quarters · filed 2026-08-05 | $238.50M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $51.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $127.60M derived: sum of 2 quarters · filed 2026-08-05 | $63.10M 10-Q · filed 2025-11-05 | $375.70M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $75.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.40M 10-Q · filed 2026-08-05 | $324.00M derived: sum of 3 quarters · filed 2026-08-05 | $366.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | -$64.50M 10-Q · filed 2026-05-06 | $248.10M derived: sum of 2 quarters · filed 2026-05-06 | $290.30M derived: sum of 3 quarters · filed 2026-05-06 | $299.80M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $312.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $354.80M derived: sum of 2 quarters · filed 2026-02-26 | $364.30M derived: sum of 3 quarters · filed 2026-02-26 | $362.90M 10-K · filed 2026-02-26 | ||||
| 2024-09-28 | $42.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $51.70M derived: sum of 2 quarters · filed 2025-11-05 | $50.30M 10-Q · filed 2025-11-05 | $259.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-29 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $8.10M 10-Q · filed 2025-08-06 | $216.80M derived: sum of 3 quarters · filed 2026-02-26 | $341.30M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | -$1.40M 10-Q · filed 2025-05-07 | $207.30M derived: sum of 2 quarters · filed 2026-02-26 | $331.80M derived: sum of 3 quarters · filed 2026-02-26 | $384.70M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $208.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $333.20M derived: sum of 2 quarters · filed 2026-02-26 | $386.10M derived: sum of 3 quarters · filed 2026-02-26 | $405.50M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $124.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $177.40M derived: sum of 2 quarters · filed 2024-11-06 | $196.80M 10-Q · filed 2024-11-06 | $382.70M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | $52.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $72.30M 10-Q · filed 2024-08-02 | $258.20M derived: sum of 3 quarters · filed 2025-02-28 | $317.40M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | $19.40M 10-Q · filed 2024-05-07 | $205.30M derived: sum of 2 quarters · filed 2025-02-28 | $264.50M derived: sum of 3 quarters · filed 2025-02-28 | $247.60M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $185.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $245.10M derived: sum of 2 quarters · filed 2025-02-28 | $228.20M derived: sum of 3 quarters · filed 2025-02-28 | $307.30M 10-K · filed 2025-02-28 | ||||
| 2022-10-01 | $59.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $42.30M derived: sum of 2 quarters · filed 2023-11-07 | $121.40M 10-Q · filed 2023-11-07 | $16.00M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | -$16.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $62.20M 10-Q · filed 2023-08-08 | -$43.20M derived: sum of 3 quarters · filed 2024-02-27 | $300.60M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | $79.10M 10-Q · filed 2023-05-09 | -$26.30M derived: sum of 2 quarters · filed 2024-02-27 | $317.50M derived: sum of 3 quarters · filed 2024-02-27 | $235.20M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$105.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $238.40M derived: sum of 2 quarters · filed 2024-02-27 | $156.10M derived: sum of 3 quarters · filed 2024-02-27 | $156.30M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | $343.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $261.50M derived: sum of 2 quarters · filed 2022-11-08 | $261.70M 10-Q · filed 2022-11-08 | $372.10M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | -$82.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$82.10M 10-Q · filed 2022-08-09 | $28.30M derived: sum of 3 quarters · filed 2023-02-28 | $91.40M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $200.00K 10-Q · filed 2022-05-11 | $110.60M derived: sum of 2 quarters · filed 2023-02-28 | $173.70M derived: sum of 3 quarters · filed 2023-02-28 | $464.60M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $110.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $173.50M derived: sum of 2 quarters · filed 2023-02-28 | $464.40M derived: sum of 3 quarters · filed 2023-02-28 | $636.20M 10-K · filed 2023-02-28 | ||||
| 2020-09-26 | $63.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $354.00M derived: sum of 2 quarters · filed 2021-11-12 | $525.80M 10-Q · filed 2021-11-12 | $615.30M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-27 | $290.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $462.70M 10-Q · filed 2021-08-11 | $552.20M derived: sum of 3 quarters · filed 2022-03-01 | $692.20M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-28 | $171.80M 10-Q · filed 2021-05-12 | $261.30M derived: sum of 2 quarters · filed 2022-03-01 | $401.30M derived: sum of 3 quarters · filed 2022-03-01 | $465.10M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $89.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $229.50M derived: sum of 2 quarters · filed 2022-03-01 | $293.30M derived: sum of 3 quarters · filed 2022-03-01 | $387.80M 10-K · filed 2022-03-01 | ||||
| 2019-09-28 | $140.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $203.80M derived: sum of 2 quarters · filed 2020-11-05 | $298.30M 10-Q · filed 2020-11-05 | $492.60M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-29 | $63.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $158.30M 10-Q · filed 2020-08-05 | $352.60M derived: sum of 3 quarters · filed 2021-03-01 | $496.60M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | $94.50M 10-Q · filed 2020-05-05 | $288.80M derived: sum of 2 quarters · filed 2021-03-01 | $432.80M derived: sum of 3 quarters · filed 2021-03-01 | $515.10M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $194.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $338.30M derived: sum of 2 quarters · filed 2021-03-01 | $420.60M derived: sum of 3 quarters · filed 2021-03-01 | $593.00M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | $144.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $226.30M derived: sum of 2 quarters · filed 2019-11-06 | $398.70M 10-Q · filed 2019-11-06 | $615.60M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $82.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $254.70M 10-Q · filed 2019-08-08 | $471.60M derived: sum of 3 quarters · filed 2020-02-27 | $668.30M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $172.40M 10-Q · filed 2019-05-09 | $389.30M derived: sum of 2 quarters · filed 2020-02-27 | $586.00M derived: sum of 3 quarters · filed 2020-02-27 | $676.80M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $216.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $413.60M derived: sum of 2 quarters · filed 2020-02-27 | $504.40M derived: sum of 3 quarters · filed 2020-02-27 | $698.90M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $196.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $287.50M derived: sum of 2 quarters · filed 2018-11-08 | $482.00M 10-Q · filed 2018-11-08 | $688.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | $90.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $285.30M 10-Q · filed 2018-08-09 | $491.50M derived: sum of 3 quarters · filed 2019-02-27 | $710.50M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | $194.50M 10-Q · filed 2018-05-08 | $400.70M derived: sum of 2 quarters · filed 2019-02-27 | $619.70M derived: sum of 3 quarters · filed 2019-02-27 | $750.90M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $206.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $425.20M derived: sum of 2 quarters · filed 2019-02-27 | $556.40M derived: sum of 3 quarters · filed 2019-02-27 | $654.90M 10-K · filed 2019-02-27 | ||||
| 2016-10-01 | $219.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $350.20M derived: sum of 2 quarters · filed 2017-11-09 | $448.70M 10-Q · filed 2017-11-09 | $703.50M 10-Q · filed 2016-11-10 | $513.60M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-07-02 | $131.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $229.70M 10-Q · filed 2017-08-10 | $399.60M 10-Q · filed 2016-08-10 | $294.60M derived: sum of 3 quarters · filed 2018-03-01 | $430.60M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-04-02 | $98.50M 10-Q · filed 2017-05-30 | $170.30M 10-Q · filed 2016-05-16 | $163.40M derived: sum of 2 quarters · filed 2018-03-01 | $299.40M derived: sum of 3 quarters · filed 2018-03-01 | $682.60M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $64.90M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $200.90M 10-K · filed 2018-03-01 | $323.20M 10-KT · filed 2016-02-25 | $584.10M derived: sum of 3 quarters · filed 2018-03-01 | $764.30M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-09-26 | $136.00M 10-Q · filed 2015-11-02 | $519.20M derived: sum of 2 quarters · filed 2017-05-22 | $617.40M 10-Q/A · filed 2017-05-23 | $866.70M 10-Q · filed 2016-11-10 | $972.00M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2015-06-27 | $383.20M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $563.40M 10-Q/A · filed 2017-05-22 | $730.70M 10-Q · filed 2016-08-10 | $836.00M derived: sum of 3 quarters · filed 2017-05-22 | $855.20M 10-K · filed 2018-03-01 | $1.20B 10-K · filed 2015-08-13 | ||
| 2015-03-28 | $180.20M 10-Q/A · filed 2017-05-22 | $268.00M 10-Q · filed 2016-05-16 | $452.80M derived: sum of 2 quarters · filed 2017-05-22 | $735.60M 10-Q · filed 2015-04-29 | $880.10M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-12-27 | $272.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $467.70M 10-Q · filed 2015-02-05 | $699.90M derived: sum of 3 quarters · filed 2017-05-22 | $880.40M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-09-27 | $195.10M 10-Q · filed 2015-11-02 | $427.30M derived: sum of 2 quarters · filed 2017-05-22 | $607.80M derived: sum of 3 quarters · filed 2017-05-22 | $729.40M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-06-28 | $232.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $412.70M derived: sum of 2 quarters · filed 2017-05-22 | $534.30M derived: sum of 3 quarters · filed 2017-05-22 | $633.00M 10-K · filed 2017-05-22 | $693.50M 10-K · filed 2014-08-14 | |||
| 2014-03-29 | $180.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $302.10M derived: sum of 2 quarters · filed 2015-04-29 | $400.80M 10-Q · filed 2015-04-29 | $574.50M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-28 | $121.60M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $220.30M 10-Q · filed 2015-02-05 | $394.00M derived: sum of 3 quarters · filed 2016-02-25 | $544.50M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-09-28 | $98.70M 8-K · filed 2014-11-20 | $0.00 10-Q · filed 2013-11-04 | $272.40M derived: sum of 2 quarters · filed 2016-02-25 | $422.90M derived: sum of 3 quarters · filed 2016-02-25 | ||||
| 2013-06-29 | $173.70M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $324.20M derived: sum of 2 quarters · filed 2016-02-25 | $553.80M 10-KT · filed 2016-02-25 | |||||
| 2013-03-30 | $150.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $380.10M 10-Q · filed 2014-05-07 | ||||||
| 2012-12-29 | $229.60M 10-Q · filed 2014-02-06 | |||||||
| 2012-06-30 | $513.40M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |